KLOW Blend Research Compound (KLOW)

"Premium grade KLOW Blend validation."

KLOW is a pre-measured research blend of TB-500 (thymosin beta-4), BPC-157, GHK-Cu, and KPV, designed for multi-pathway research combining actin-binding, cytoprotective, copper-binding, and anti-inflammatory tripeptide activities. Component peptides are documented in the literature: thymosin beta-4 (Goldstein et al., Trends Mol Med 2005, PMID 16099219), BPC-157 (Sikiric et al., Curr Pharm Des 2011, PMID 21548867), GHK-Cu (Pickart et al., Oxid Med Cell Longev 2012, PMC3359723), and KPV (Dalmasso et al., Gastroenterology 2008, PMID 18061177). KLOW blend research peptide is supplied lyophilized at ≥99% purity verified by HPLC, with identity confirmed by mass spectrometry and a batch-specific Certificate of Analysis (COA) included. Store lyophilized powder at −20 °C, protected from light and moisture. For laboratory research use only — not for human or animal consumption.